REGISTERED
on 25 Jun 2024
Last Applicant/ Owned by
3-5-1, Nihonbashi Honcho, Chuo-ku
Tokyo
JP
103-8426
Serial Number
98022183 filed on 31st May 2023
Registration Number
7426347 registered on 25th Jun 2024
Correspondent Address
Molly Hunsinger
Filing Basis
No Filing Basis
Disclaimer
NO DATA
AGANTRYS
Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases, fibrodysplasia ossificans progressive, systemic lupus erythematosus, Netherton syndrome; Vaccines
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases, fibrodysplasia ossificans progressive, systemic lupus erythematosus, Netherton syndrome; Vaccines
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98022183
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 3T23790315
44D Filed
No
44D Current
No
44E filed
Yes
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 25th Jun 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 25th Jun 2024 | REGISTERED-PRINCIPAL REGISTER |
| 09th Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 09th Apr 2024 | PUBLISHED FOR OPPOSITION |
| 20th Mar 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 01st Mar 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 22nd Feb 2024 | ASSIGNED TO EXAMINER |
| 03rd Jul 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 03rd Jun 2023 | NEW APPLICATION ENTERED |